Antifungal susceptibility testing of yeast isolates from blood cultures by microbroth dilution and the E test

被引:25
作者
Simor, AE
Goswell, G
Louie, L
Lee, M
Louie, M
机构
[1] Department of Microbiology, Sunnybrook Health Science Centre, University of Toronto, North York, Ont. M4N 3M5
关键词
D O I
10.1007/BF01708563
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The results of microbroth dilution were compared with those of the E test for 169 yeast isolates tested for their susceptibility to antifungal agents. All isolates were tested by both methods against amphotericin B, ketoconazole, fluconazole, and itraconazole. The E test results generally correlated well with those obtained by the reference method. There was at least 80% agreement of minimum inhibitory concentration results within two dilutions for all yeast species and agents tested, except for Cryptococcus neoformans tested with fluconazole (8% agreement). The E test appears to be a suitable alternative antifungal susceptibility test method for yeasts, although improvements are required for testing Cryptococcus neoformans against fluconazole.
引用
收藏
页码:693 / 697
页数:5
相关论文
共 15 条
[1]   Antifungal susceptibility testing using the E test: Comparison with the broth macrodilution technique [J].
Chen, SCA ;
ODonnell, ML ;
Gordon, S ;
Gilbert, GL .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1996, 37 (02) :265-273
[2]   EVALUATION OF THE E-TEST SYSTEM VERSUS A MICROTITRE BROTH METHOD FOR ANTIFUNGAL SUSCEPTIBILITY TESTING OF YEASTS AGAINST FLUCONAZOLE AND ITRACONAZOLE [J].
COLOMBO, AL ;
BARCHIESI, F ;
MCGOUGH, DA ;
FOTHERGILL, AW ;
RINALDI, MG .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1995, 36 (01) :93-100
[3]   ETEST FOR ANTIFUNGAL SUSCEPTIBILITY TESTING OF YEASTS [J].
ESPINELINGROFF, A .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1994, 19 (04) :217-220
[4]   Susceptibility testing of fungi: Current status of correlation of in vitro data with clinical outcome [J].
Ghannoum, MA ;
Rex, JH ;
Galgiani, JN .
JOURNAL OF CLINICAL MICROBIOLOGY, 1996, 34 (03) :489-495
[5]   HIGH PREVALENCE OF ANTIFUNGAL RESISTANCE IN CANDIDA SPP FROM PATIENTS WITH AIDS [J].
LAW, D ;
MOORE, CB ;
WARDLE, HM ;
GANGULI, LA ;
KEANEY, MGL ;
DENNING, DW .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1994, 34 (05) :659-668
[6]  
*NAT COMM CLIN LAB, 1995, M27T NCCLS
[7]   IMPACT OF THE CHANGING EPIDEMIOLOGY OF FUNGAL-INFECTIONS IN THE 1990S [J].
PFALLER, M ;
WENZEL, R .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1992, 11 (04) :287-291
[8]   Multisite reproducibility of the Etest MIC method for antifungal susceptibility testing of yeast isolates [J].
Pfaller, MA ;
Messer, SA ;
Bolmstrom, A ;
Odds, FC ;
Rex, JH .
JOURNAL OF CLINICAL MICROBIOLOGY, 1996, 34 (07) :1691-1693
[9]   ANTIFUNGAL SUSCEPTIBILITY TESTING OF ISOLATES FROM A RANDOMIZED, MULTICENTER TRIAL OF FLUCONAZOLE VERSUS AMPHOTERICIN-B AS TREATMENT OF NONNEUTROPENIC PATIENTS WITH CANDIDEMIA [J].
REX, JH ;
PFALLER, MA ;
BARRY, AL ;
NELSON, PW ;
WEBB, CD .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (01) :40-44
[10]   Development of interpretive breakpoints for antifungal susceptibility testing: Conceptual framework and analysis of in vitro in vivo correlation data for fluconazole, itraconazole, and Candida infections [J].
Rex, JH ;
Pfaller, MA ;
Galgiani, JN ;
Bartlett, MS ;
EspinelIngroff, A ;
Ghannoum, MA ;
Lancaster, M ;
Odds, FC ;
Rinaldi, MG ;
Walsh, TJ ;
Barry, AL .
CLINICAL INFECTIOUS DISEASES, 1997, 24 (02) :235-247